Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Media News.
Press releases published on June 20, 2025
Media Alert: House of Good Presents the Well+Good Shop
GlobeNewswire
·
June 20, 2025
VENICE, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Join Well+Good IRL at House of Good to shop feel-good products across home, beauty, fitness, tech, and more all month. WHAT: Escape the hustle of Abbot Kinney and enter into a feel-good emporium—curated …
Texas Housing Market Slows in 2025, But Investor Buyers Remain Active
GlobeNewswire
·
June 20, 2025
Deer Park, TX, June 20, 2025 (GLOBE NEWSWIRE) -- As the Texas real estate market cools, it’s beginning to rebalance. Inventory is increasing, price growth is slowing, and homes are staying on the market longer, especially those that need updates or are …
Kopila Valley School makes Final 10 for World’s Best School Prize for Environmental Action
GlobeNewswire
·
June 20, 2025
Surkhet, Nepal, June 20, 2025 (GLOBE NEWSWIRE) -- An extraordinary Nepalese school has today been named a Top 10 finalist for the World’s Best School Prizes 2025. The five World’s Best School Prizes, founded by T4 Education in the wake of COVID in 2022 to …
PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
GlobeNewswire
·
June 20, 2025
MINNEAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the …
Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire
·
June 20, 2025
REDWOOD CITY, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced one oral and six poster presentations …
BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
GlobeNewswire
·
June 20, 2025
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …
Patriot Mobile Receives Second Amendment Business Champion Award
GlobeNewswire
·
June 20, 2025
Washington, D.C., June 20, 2025 (GLOBE NEWSWIRE) -- Patriot Mobile was recognized with the Second Amendment Business Champion award at the 5th Annual Second Amendment Champion Ceremony, hosted by the Second Amendment Institute (SAI) last night in …
SkyCrest Capital Launches “Pension Plan” to Redefine Structured Asset Execution
GlobeNewswire
·
June 20, 2025
Denver, USA, June 20, 2025 (GLOBE NEWSWIRE) -- SkyCrest Capital today announced the official launch of its strategic structured asset execution initiative—the “Pension Plan”—set to go live on Monday, June 23, 2025. Built upon the firm's proprietary SAX- …
Digital Asset Technologies Celebrates GENIUS Act as Pivotal Moment for U.S. Leadership in Digital Finance
GlobeNewswire
·
June 20, 2025
VANCOUVER, BC, June 20, 2025 (GLOBE NEWSWIRE) -- Digital Asset Technologies Inc. (CSE: DATT) (OTCPK: EATBF) (FSE: 988) (“Digital Asset Technologies” or the “Company”) and its portfolio company LiquidLink AI Corp. (“LinkLink”), strongly supports the U.S. …
Jeffs’ Brands and Impact Acquisitions Receive Approval from TSX Venture Exchange for Fort Products’ Merger at a Valuation of up to Approximately $15 Million
GlobeNewswire
·
June 20, 2025
Tel Aviv, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that the TSX Venture Exchange (“TSXV”) has …
GoPath Diagnostics Announces Launch of DiabetesNow: A Genetic Test Panel Designed to Clarify Diabetes Diagnosis
GlobeNewswire
·
June 20, 2025
Buffalo Grove, IL, June 20, 2025 (GLOBE NEWSWIRE) -- A More Complete Genetic View of Diabetes DiabetesNow combines testing for 16 genes associated with monogenic forms of diabetes—including MODY, neonatal, syndromic, and mitochondrial types—with polygenic …
Ellomay Capital Announces the Closing of the Investment by Clal Insurance in Ellomay Capital’s 198 MW Italian Solar Portfolio
GlobeNewswire
·
June 20, 2025
Tel-Aviv, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, …
Euroopan lääkeviraston ihmislääkekomitealta (CHMP) myönteinen lausunto darolutamidin kolmannelle käyttöaiheelle edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
GlobeNewswire
·
June 20, 2025
ORION OYJ LEHDISTÖTIEDOTE 20.6.2025 klo 13.30 Euroopan lääkeviraston ihmislääkekomitealta (CHMP) myönteinen lausunto darolutamidin kolmannelle käyttöaiheelle edennyttä eturauhassyöpää sairastavien potilaiden hoidossa CHMP suosittaa myyntiluvan …
CHMP recommends third indication for darolutamide for patients with advanced prostate cancer
GlobeNewswire
·
June 20, 2025
ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients with advanced prostate cancer CHMP adopts positive opinion for the marketing authorisation of darolutamide in combination …
Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors
GlobeNewswire
·
June 20, 2025
If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy1,2 Recommendation …
Ipsen reçoit un avis positif du CHMP pour Cabometyx® dans les tumeurs neuroendocrines avancées précédemment traitées
GlobeNewswire
·
June 20, 2025
S’il est approuvé, Cabometyx® sera le premier et unique traitement systémique autorisé dans l’Union européenne pour les tumeurs neuroendocrines précédemment traitées, indépendamment de la localisation de la tumeur, de sa gravité et de l’administration ou …
YouTube Oscars’ for Women Micro-Influencers: The Helen Keller Award Reveals 2025 Finalists
GlobeNewswire
·
June 20, 2025
St. Petersburg, Florida , June 20, 2025 (GLOBE NEWSWIRE) -- The Helen Keller Award, often referred to as the “YouTube Oscars” for women micro-influencers, has announced its list of 2025 finalists. Only creators with up to 50,000 subscribers were considered …
One More Child Begins Lakeland Campus Expansion to Serve More Families
GlobeNewswire
·
June 20, 2025
LAKELAND, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- One More Child held a special groundbreaking ceremony this week to kick off its multi-phase campus expansion project, allowing the organization to serve more children and families in need. Community …
Everything Blockchain Plans $10M Strategic Acquisition of SOL, XRP, SUI, TAO & HYPE — Front Running Wall Street
GlobeNewswire
·
June 20, 2025
Jacksonville, Florida, June 20, 2025 (GLOBE NEWSWIRE) -- Everything Blockchain Inc. (OTC: EBZT) announced today its strategic plan to deploy $10 million into five of the fastest growing blockchain networks—Solana (SOL), XRP, Sui (SUI), Bittensor (TAO), and …
Vereigen Media Strengthens Its Position as a Human-First B2B Demand Generation Company in the Age of AI Automation
GlobeNewswire
·
June 20, 2025
AUSTIN, Texas, June 20, 2025 (GLOBE NEWSWIRE) -- In a world dominated by AI and automation, Vereigen Media is redefining B2B demand generation with a human-first approach. While many rely on automated outreach, Vereigen doubles down on people, process, and …